Production of SART with innovative photo-oxydation technology.
Sanofi S.p.A. in 2014.
1982-1983 Implementation of several new productions in the Garessio Site, incl. Urokinase, thrombolytics, Terfenadine and antihistaminics.
1981 – 1999 After successive mergers, the entity, renamed MMD is sold to the German group Hoechst, and becomes Aventis Pharma in 1999.
The US group Dow Chemical acquires a majority stake in Lepetit.
1935 - 1949 The site progressively extends its production to the synthesis of vitamin D, K, PP, folic acid and Chloramphenicol, the first antibiotic by synthesis produced in Italy.
The Garessio Site produces more than 10,000 tons of APIs, chestnut extracts, tanning extracts and inks.
The pharmaceutical division takes the name of Lepetit S.A.
Start of production of Almateina, the first pharmaceutical product produced at an industrial scale in Italy.
Establishment of the Garessio chemical plant, with a surface of 8,000 sq.m. and 70 operators.